Henan Newland Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Xintiandi Pharmaceutical Co., Ltd., located in Changge Economic and Technological Development Zone, Henan Province, was founded in 2005 with a registered capital of 100 million yuan. Mainly engaged in the research and development, production, and sales of pharmaceutical intermediates and raw materials, it is an important global production enterprise for the side chain of amoxicillin synthesis - L-p-hydroxyphenylglycine. It has led or participated in the development of industry standards for multiple products such as L-p-hydroxyphenylglycine, p-toluenesulfonic acid, and L-p-hydroxyphenylglycine methyl ester. It is the second batch of specialized, refined, and new enterprises in Henan Province. |
| Headquarter | Xuchang |
| Establish Date | 9/15/2005 |
| Listed Code | 301277.SZ |
| Listed Date | 11/16/2022 |
| Chairman | Xie Jianzhong. |
| CEO | Zhang Luwei. |
| Website | www.newlandpharma.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
